Clinical trial highlights

Targetting alpha-synuclein

Kevin McFarthing, Tatyana Simuni

Research output: Contribution to journalReview article

Original languageEnglish (US)
Pages (from-to)5-16
Number of pages12
JournalJournal of Parkinson's disease
Volume9
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

alpha-Synuclein
Clinical Trials

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

@article{2895bab1147e4e88808403b2e816b37f,
title = "Clinical trial highlights: Targetting alpha-synuclein",
author = "Kevin McFarthing and Tatyana Simuni",
year = "2019",
month = "1",
day = "1",
doi = "10.3233/JPD-189004",
language = "English (US)",
volume = "9",
pages = "5--16",
journal = "Journal of Parkinson's Disease",
issn = "1877-7171",
publisher = "IOS Press",
number = "1",

}

Clinical trial highlights : Targetting alpha-synuclein. / McFarthing, Kevin; Simuni, Tatyana.

In: Journal of Parkinson's disease, Vol. 9, No. 1, 01.01.2019, p. 5-16.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Clinical trial highlights

T2 - Targetting alpha-synuclein

AU - McFarthing, Kevin

AU - Simuni, Tatyana

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85061216277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061216277&partnerID=8YFLogxK

U2 - 10.3233/JPD-189004

DO - 10.3233/JPD-189004

M3 - Review article

VL - 9

SP - 5

EP - 16

JO - Journal of Parkinson's Disease

JF - Journal of Parkinson's Disease

SN - 1877-7171

IS - 1

ER -